Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis

Journal of Cardiovascular Magnetic Resonance

Volumn 10, Issue 1, 2008, Pages

  Maceira, Alicia M ^a   Prasad, Sanjay K ^b   Hawkins, Philip N ^c   Roughton, Michael ^b   Pennell, Dudley J ^b  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; IMMUNOGLOBULIN LIGHT CHAIN; IODINE 123; SERUM AMYLOID P; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG CLEARANCE; DRUG UPTAKE; FEMALE; FOLLOW UP; HEART AMYLOIDOSIS; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HEART SIZE; HUMAN; IMAGING SYSTEM; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; T1 MAPPING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AMYLOIDOSIS; BIOPSY; BLOOD; CARDIOMYOPATHY; HEART MUSCLE; HOSPITALIZATION; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK ASSESSMENT; TIME;

AGED; AMYLOIDOSIS; BIOLOGICAL MARKERS; BIOPSY; CARDIOMYOPATHIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GADOLINIUM DTPA; HUMANS; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 58749099485     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-10-54     Document Type: Article

References (29)

1. Falk RH, Comenzo RL, Skinner M: The systemic amyloidoses. N Engl J Med 1997, 337: 898-909. (Pubitemid 27408573)
2. Kyle RA, Greipp PR, O'Fallon WM: Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood 1986, 68: 220-224.
3. Arbustini E, Gavazzi A, Merlini G: Fibril-forming proteins: the amyloidosis: new hopes for a disease that cardiologists must know. Ital Heart J Suppl 2002, 3(6): 590-597. (Pubitemid 34803522)
4. Nihoyannopoulos P: Amyloid heart disease. Current Opin Cardiol 1987, 2: 371-376.
5. Falk RH, Skinner M: The systemic amyloidoses: an overview. Adv Intern Med 2000, 45: 107-137.
6. Maceira AM, Joshi J, Prasad SK, Moon JCC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell D: Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111: 195-202. (Pubitemid 40139730)
7. Klein AL, Hatle LK, Burstow DJ, Seward JB, Kyle RA, Bailey KR, Luscher TF, Gertz MA, Tajik AJ: Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1989, 13: 1017-1026. (Pubitemid 19091289)
8. Moyssakis I, Tripdskiadis F, Rallidis L, Hawkins P, Kyriakidis M, Nihoyannopoulos P: Echocardiographic features of primary, secondary and familial amyloidosis. Eur J Clin Invest 1999, 29: 484-489. (Pubitemid 29271638)
9. Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, Hawkins PN: Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003, 122: 78-84. (Pubitemid 36819341)
10. Maceira AM, Prasad SK, Khan M, Pennell DJ: Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006, 8: 417-426.
11. Sueyoshi E, Sakamoto I, Okimoto T, Hayashi K, Tanaka K, Toda G: Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrastenhanced MRI. Cardiovasc Intervent Radiol 2006, 29: 710-712. (Pubitemid 43823029)
12. Cheng AS, Banning AP, Mitchell AR, Neubauer S, Selvanayagam JB: Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging. Int J Cardiol 2006, 113: E21-3. (Pubitemid 44648376)
13. Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L, Salvi F, Lovato L, Branzi A, Fattori R: Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006, 92: 343-349. (Pubitemid 43295102)
14. Cacoub P, Axler O, De Zuttere D, Hausfater P, Amoura Z, Walter S, Wechsler B, Godeau P, Piette JC: Amyloidosis and cardiac involvement. Ann Med Interne (Paris) 2000, 151(8): 611-617. (Pubitemid 32109349)
15. Kristen AV, Perz JB, Schonland SO, Hegenbart U, Schnabel PA, Kristen JH, Goldschmidt H, Katus HA, Dengler TJ: Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007, 9: 617-624. (Pubitemid 46702816)
16. Klein AL, Hatle LK, Taliercio CP, Oh JK, Kyle RA, Gertz MA, Bailey KR, Seward JB, Tajik AJ: Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991, 83: 808-816.
17. Palladini G, Lavatelli F, Russo P, Perlini S, Perfetti V, Bosoni T, Obici L, Bradwell AR, D'Eril GM, Fogari R, Moratti R, Merlini G: Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL. Blood 2006, 107: 3854-3858. (Pubitemid 43726787)
18. Kholova I, Kautzner J: Current treatment in cardiac amyloidosis. Curr Treat Options Cardiovasc Med 2006, 8: 468-473. (Pubitemid 44742129)
19. Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN: Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 2002, 417: 254-259. (Pubitemid 34534701)
20. Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Puechal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M, Eprodisate for AA Amyloidosis Trial Group: Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med 2007, 356: 2349-2360.
21. Gillmore JD, Goodman HJ, Lachmann HJ, Offer M, Wechalekar AD, Joshi J, Pepys MB, Hawkins PN: Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006, 107: 1227-1229. (Pubitemid 43156329)
22. Maurer MS, Raina A, Hesdorffer C, Bijou R, Colombo P, Deng M, Drusin R, Haythe J, Horn E, Lee SH, Marboe C, Naka Y, Schulman L, Scully B, Shapiro P, Prager K, Radhakrishnan J, Restaino S, Mancini D: Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation 2007, 83: 539-545. (Pubitemid 46440239)
23. Shah KB, Inoue Y, Mehra MR: Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006, 166: 1805-1813. (Pubitemid 44455160)
24. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41: 1561-1567.
25. Assomull RG, Prasad SK, Lyne J, Smith GC, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48: 1977-1985. (Pubitemid 44738448)
26. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, Anderson LJ, Walker JM, Pennell DJ: Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006, 8: 543-547.
27. Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ: The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006, 8: 479-482.
28. Anderson LJ, Holden S, Davies B, Prescott E, Charrier C, Bunce NH, Firmin DN, Porter JB, Wonke B, Walker JM, Pennell DJ: Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22: 2171-2179. (Pubitemid 33139463)
29. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G: Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005, 79: 319-328. (Pubitemid 41098849)